Figure 3From: BCL11A overexpression predicts survival and relapse in non-small cell lung cancer and is modulated by microRNA-30a and gene amplificationKaplan-Meier estimated overall survival and disease-free survival curves of NSCLC patients according to BCL11A protein level. (A) Overall survival of all 113 NSCLC patients. (B) Disease-free survival of all 113 NSCLC patients. (C) Overall survival of 88 early stage NSCLC patients. (D) Disease-free survival of 88 early stage NSCLC patients. (E) Overall survival of 31 patients with early stage squamous cell lung cancer. (F) Disease-free survival of 31 early stage squamous cell lung cancer patients. P values were calculated by log rank tests.Back to article page